OTC Markets OTCPK - Delayed Quote USD
Bumrungrad Hospital Public Company Limited (BUHPF)
4.8500
0.0000
(0.00%)
At close: May 2 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
25,321,945.3170
25,717,577.3170
25,376,158.5600
20,720,563.6550
12,460,420.9420
Cost of Revenue
12,396,861.1100
12,503,044.1100
12,894,825.8680
11,099,259.8070
7,730,980.5290
Gross Profit
12,925,084.2070
13,214,533.2070
12,481,332.6920
9,621,303.8480
4,729,440.4130
Operating Expense
4,052,354.2870
4,026,463.2870
4,009,390.6680
3,610,975.1950
3,151,810.2930
Operating Income
8,872,729.9200
9,188,069.9200
8,471,942.0240
6,010,328.6530
1,577,630.1200
Net Non Operating Interest Income Expense
273,132.4200
271,138.4200
138,554.8940
42,407.4830
-50,971.4170
Other Income Expense
-34,701.2800
-23,161.2800
27,158.3350
-3,780.6440
-70,779.0250
Pretax Income
9,111,161.0600
9,436,047.0600
8,637,655.2530
6,048,955.4920
1,455,879.6780
Tax Provision
1,534,654.0830
1,603,990.0830
1,582,523.6020
1,072,193.3190
215,846.9060
Net Income Common Stockholders
7,523,719.8760
7,774,725.8760
7,006,450.9790
4,938,221.8500
1,215,678.2260
Diluted NI Available to Com Stockholders
7,523,719.8760
7,774,725.8760
7,006,450.9790
4,938,221.8500
1,215,678.2260
Basic EPS
9.46
9.78
8.81
6.21
1.53
Diluted EPS
8.67
8.96
8.08
5.69
1.40
Basic Average Shares
794,920
794,911
794,886
794,838
794,586
Diluted Average Shares
867,415
867,415
867,415
867,415
867,415
Total Operating Income as Reported
8,838,452.9220
9,165,335.9220
8,499,997.6470
6,007,057.9780
1,519,269.0380
Rent Expense Supplemental
--
85,719
71,031
46,112
--
Total Expenses
16,449,215.3970
16,529,507.3970
16,904,216.5360
14,710,235.0020
10,882,790.8220
Net Income from Continuing & Discontinued Operation
7,523,719.8760
7,774,725.8760
7,006,450.9790
4,938,221.8500
1,215,678.2260
Normalized Income
7,552,223.3689
7,793,595.4266
6,983,535.4877
4,940,912.7892
1,265,386.7667
Interest Income
281,383.2320
279,473.2320
140,948.4620
45,954.2720
68,784.4800
Interest Expense
8,250.8120
8,334.8120
2,393.5680
3,546.7890
119,755.8970
Net Interest Income
273,132.4200
271,138.4200
138,554.8940
42,407.4830
-50,971.4170
EBIT
9,119,411.8720
9,444,381.8720
8,640,048.8210
6,052,502.2810
1,575,635.5750
EBITDA
10,185,447.8720
10,521,617.8720
9,736,816.8210
7,169,377.2810
2,755,557.2100
Reconciled Cost of Revenue
12,396,861.1100
12,503,044.1100
12,894,825.8680
11,099,259.8070
7,730,980.5290
Reconciled Depreciation
1,066,036
1,077,236
1,096,768
1,116,875
1,179,921.6350
Net Income from Continuing Operation Net Minority Interest
7,523,719.8760
7,774,725.8760
7,006,450.9790
4,938,221.8500
1,215,678.2260
Total Unusual Items Excluding Goodwill
-34,276.9980
-22,733.9980
28,055.6230
-3,270.6750
-58,361.0820
Total Unusual Items
-34,276.9980
-22,733.9980
28,055.6230
-3,270.6750
-58,361.0820
Normalized EBITDA
10,219,724.8700
10,544,351.8700
9,708,761.1980
7,172,647.9560
2,813,918.2920
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0001
Tax Effect of Unusual Items
-5,773.5051
-3,864.4474
5,140.1317
-579.7358
-8,652.5413
12/31/2021 - 4/26/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade